Menopause Management & Guidelines
Published: May 2026
This course explores the evolving landscape of menopause medicine, from navigating FDA black box warnings and optimizing hormone therapy to addressing gender disparities, patient education, and evidence-based management of genitourinary syndrome of menopause (GSM). The conversation highlights guideline-driven care, advocacy for vaginal estrogen access, multidisciplinary collaboration, and patient-centered dosing strategies. Join Drs. Suzette Sutherland, Yahir Santiago-Lastra, Kelly Casperson, Rachel Rubin, Melissa Kaufman, and Giulia Ippolito as they share expert perspectives on advancing outcomes for women’s health.
3 hours, 29 lessons
Course Preview
Lesson 23 • 17 Jan 2025
Lessons
Navigating Regulation, Advocacy & Evidence for Hormone Therapy in Menopause Care
Lesson 1
Lesson 2
Advocacy and Evidence: The Path Toward Updated Vaginal Estrogen Labeling
Lesson 3
Evidence Gaps and Gender Disparities in Hormone Therapy and Menopause Management
Lesson 4
Expanding the Role of Vaginal Estrogen for GSM Symptoms: Urinary, Genital, and Sexual Health
Lesson 5
Vaginal Estrogen for Recurrent UTIs: Clinical Evidence, Healthcare Burden, and Advocacy for Access
Lesson 6
Coordinated Advocacy Strategies for Vaginal Estrogen: FDA and Legislative Barriers
Hormone Replacement Therapy in Menopause: Dispelling Myths & Optimizing Outcomes
Lesson 7
HRT Risk Reassessment: Dispelling Myths and Insights from WHI Data
Lesson 8
WHI Study Design Limitations and Media Impact on HRT Risk Interpretation
Lesson 9
Lesson 10
Consequences of Inadequate Education, Misdiagnosis, and Provider Barriers in Menopause Management
Lesson 11
Hormone Therapy in Menopause: Risks of Nonuse and Impact on Longevity
Lesson 12
The Role of Hormones in Preventing Dementia and Cognitive Aging
Lesson 13
Genitourinary Syndrome of Menopause Management: Guidelines, Therapies & Surveillance
Lesson 14
Guideline Creation: Evidence, Expert Opinion, and Clinical Principles in GSM
Lesson 15
Multidisciplinary Referrals and Shared Decision-Making in GSM Guidelines
Lesson 16
Overcoming Barriers: Insurance, Safety, and Efficacy of Long-Term Use of Vaginal Estrogen for GSM
Lesson 17
Clinical Guidelines for GSM: Treatment Selection and Symptom Targeting
Lesson 18
Vaginal Estrogen vs. Alternatives: Evidence for Urinary Symptom Management
Lesson 19
Non-Hormonal GSM Management: Guidelines, Efficacy, and Patient Counseling
Lesson 20
Lesson 21
Endometrial Surveillance and Follow-Up Timelines in Vaginal Estrogen Therapy
Advancing Menopause Medicine: Multidisciplinary Responsibility, Dosing Strategies & Patient-Centered Management
Lesson 22
Specialty Ownership and Training Deficits in Menopause and HRT Management
Lesson 23
Lesson 24
Evolving Best Practices in HRT: Lessons from WHI and Recent Studies
Lesson 25
Practical Approaches to Prescribing Hormone Therapy: Optimizing Dosing and Delivery Methods
Lesson 26
Clinical Considerations for Combining Systemic and Vaginal Estrogen in Menopause Therapy
Lesson 27
Patient-Centered Education and Dosing Strategies in Menopause Hormone Therapy
Lesson 28
Sequencing Estrogen, Progesterone, and Testosterone in Menopause Therapy
Lesson 29
Lab Testing and Patient-Centered Management in Female Hormone Therapy